Monday, May 8, 2023

Mirati Therapeutics Teams To Increase Clinical Study Diversity

San Diego-based Mirati Therapeutics, a biotechnology company, says it is working with Sarah Cannon Research Institute (SCRI) to help it boost diversity in clinical study recruitment practices. The two said they hope to increase diversity in oncology clinical studies. Financial details of the deal were not announced. Mirati Therapeutics is initially focusing on lung caner.